Int'l : +1-503-894-6022 | Toll Free : +1-800-792-5285 | help@alliedmarketresearch.com
A00056 | Pages: 284 | Charts: 55 | Tables: 128 |
The global bioinformatics market size generated $8,614.29 million in 2019, and is projected to reach $24,731.61 million by 2027, growing at a CAGR of 13.4% from 2020 to 2027. Bioinformatics is a combination of biology and information technology, which links biological data with techniques for information storage, distribution, and analysis to support multiple areas of scientific research, including biomedicine. It uses software tools for database creation, data management, data warehousing, data mining, and others. Mining such data leads to scientific discoveries, which is used in the study of genetics & genomes. Several bioinformatics tools are available in the market. They are categorized as protein functional & analysis tools, homology & similarity tools, sequence analysis tools, and miscellaneous tools. The field covers many advanced and specialized areas of life such as structural genomics, functional genomics, DNA microarrays, comparative genomics, and medical information. Hence, these aforementioned factors boost the global bioinformatics market share.
Some industries have struggled, owing to the COVID-19 pandemic, and some industries have positive impact and one of those is the bioinformatics industry. This industry was already a fast-growing industry even before the COVID-19 crisis hit. This is attributed to bioinformatics tools, which can handle large volumes of biological data. Its a term that was initially coined with the first sharing of biological sequence data and has now become a multi-disciplinary area, which is of acute relevance in the current time.
Get more information on this report : Request Sample Pages
The global bioinformatics market is expected to register substantial growth in the near future, owing to rise in need for integrated data, rise in demand for nucleic acid & protein sequencing, owing to reduction in sequencing cost, and increase in applications of proteomics & genomics. In addition, drug discovery & development and initiatives from government & private organizations are expected to boost the market growth during the forecast period. However, lack of skilled personnel, common data formats, and lack of user-friendly tools at cheaper prices are projected to hamper the market growth during the forecast period. Conversely, increase in need for integrated solutions & systems, integration of machine learning & AI in healthcare and software companies investing in the development of bioinformatics solutions are expected to offer remunerative market opportunities to bioinformatics solution developers.
[TECHNOLOGY&SERVICESGRAPH]
Get more information on this report : Request Sample Pages
On the basis of technology & services, the bioinformatics market is segmented into knowledge management tools, bioinformatics platforms, and bioinformatics services. The bioinformatics platforms segment was the major revenue contributor in 2019, and is anticipated to continue this trend during the forecast period, owing to increase in platform applications and need for better tools in drug development. Increase in platform application is attributed to surge in need from the life science firm for identification and modification of structures. This, in turn, would help in drug designing process and evaluation of their therapeutic effects. Furthermore, efficiency and safety in drug development and discovery leads to increase in need for better tools in drug development. Thus, is expected to propel the bioinformatics market size in the future.
[APPLICATIONGRAPH]
Get more information on this report : Request Sample Pages
Depending on application, the bioinformatics market is categorized into metabolomics, molecular phylogenetics, transcriptomics, proteomics, chemoinformatics & drug design, genomics, and others. The transcriptomics segment is projected to exhibit the highest growth during the forecast period, owing to increase in preference in companion diagnostics and personalized medicines. Moreover, novel gene sequencing, continuous discovery of biomarkers, and worldwide acceptance of transcriptomics technology are expected to drive the bioinformatics market growth.
[REGIONGRAPH]
Get more information on this report : Request Sample Pages
Region wise, the bioinformatics market is analyzed across North America, Europe, Asia-Pacific, and LAMEA. North America dominated the market in 2019, accounting for the highest share, and is anticipated to maintain this trend throughout the forecast period. This is attributed to surge in adoption of advanced technology and increase in demand for better bioinformatics tools, which are required in drug discovery and development process. The market in LAMEA is expected to grow at the highest CAGR during the forecast period, owing to advancements in the field of genomics and proteomics, generating massive volume of data, which is to be interpreted and managed. In addition, the bioinformatics sector is still in its infancy stage in the region where research activities are developing gradually. Thus, all these factors together contribute toward growth of the market.
The report provides a comprehensive analysis of the key players operating in the global bioinformatics industry, namely, Agilent Technologies, Inc., Biomax Informatics AG, DNAnexus, Inc., Genedata AG, Intrexon Bioinformatics Germany GmbH, Illumina Inc., Perkinelmer Inc., Qiagen N.V., Seven Bridges Genomics Inc., and Thermo Fisher Scientific, Inc. The other players in the value chain include Geneva Bioinformatics (Genebio), Dassault Systems, Eurofins Scientific, Bruker Daltonics Inc., Accelrys, Inc., Affymetrix, Inc., SA Nonlinear Dynamics, and Quest Diagnostics, Inc.
Key Market Segments
Key Market Players
CHAPTER 1:INTRODUCTION
1.1.Report description
1.2.Key benefits for stakeholders
1.3.Key market segments
1.4.Research methodology
1.4.1.Secondary research
1.4.2.Primary research
1.4.3.Analyst tools & models
CHAPTER 2:EXECUTIVE SUMMARY
2.1.CXO perspective
CHAPTER 3:MARKET OVERVIEW
3.1.Market definition and scope
3.2.Key findings
3.2.1.Top investment pockets
3.2.2.Top winning strategies
3.3.Top player positioning, 2019
3.4.Market dynamics
3.4.1.Drivers
3.4.1.1.Rise in need for integrated data
3.4.1.2.Increase in growth in proteomics & genomics
3.4.1.3.Drug discovery and development
3.4.2.Restraints
3.4.2.1.Lack of skilled personnel
3.4.2.2.Common data formats
3.4.3.Opportunity
3.4.3.1.Increase in need for integrated solutions & systems
3.5.Porter’s five forces analysis
3.6.Key regulations
3.7.Value chain analysis
3.8.Bioinformatics in the drug development process
3.9.Patent analysis
3.10.Case studies
3.11.Impact analysis of COVID-19 on market
3.11.1.Overview
3.11.2.Impact of COVID-19 on bioinformatics market
CHAPTER 4:BIOINFORMATICS MARKET, BY TECHNOLOGY & SERVICES
4.1.Overview
4.1.1.Market size and forecast
4.2.Knowledge management tools
4.2.1.Key market trends, growth factors, and opportunities
4.2.2.Market size and forecast, by type
4.2.2.1.Generalized knowledge management tools
4.2.2.1.1.Market size and forecast
4.2.2.2.Specialized knowledge management tools
4.2.2.2.1.Market size and forecast
4.2.3.Market size and forecast, by region
4.2.4.Market analysis, by country
4.3.Bioinformatics platforms
4.3.1.Key market trends, growth factors, and opportunities
4.3.2.Market size and forecast, by type
4.3.2.1.Sequence analysis platforms
4.3.2.1.1.Market size and forecast
4.3.2.2.Sequence alignment platforms
4.3.2.2.1.Market size and forecast
4.3.2.3.Sequence manipulation platforms
4.3.2.3.1.Market size and forecast
4.3.2.4.Structural analysis platforms
4.3.2.4.1.Market size and forecast
4.3.2.5.Others
4.3.2.5.1.Market size and forecast
4.3.3.Market size and forecast, by region
4.3.4.Market analysis, by country
4.4.Bioinformatics services
4.4.1.Key market trends, growth factors, and opportunities
4.4.2.Market size and forecast, by type
4.4.2.1.Sequence services
4.4.2.1.1.Market size and forecast
4.4.2.2.Database management
4.4.2.2.1.Market size and forecast
4.4.2.3.Data analysis
4.4.2.3.1.Market size and forecast
4.4.2.4.Others
4.4.2.4.1.Market size and forecast
4.4.3.Market size and forecast, by region
4.4.4.Market analysis, by country
CHAPTER 5:BIOINFORMATICS MARKET, BY APPLICATION
5.1.Overview
5.1.1.Market size and forecast, by region
5.2.Genomics
5.2.1.Market size and forecast, by region
5.2.2.Market analysis, by country
5.3.Chemoinformatics & drug design
5.3.1.Market Size and Forecast, By Region
5.3.2.Market analysis, by country
5.4.Proteomics
5.4.1.Market Size and Forecast, by region
5.4.2.Market analysis, by country
5.5.Transcriptomics
5.5.1.Market size and forecast
5.5.2.Market analysis, by country
5.6.Metabolomics
5.6.1.Market size and forecast
5.6.2.Market analysis, by country
5.7.Molecular phylogenetics
5.7.1.Market size and forecast
5.7.2.Market analysis, by country
5.8.Others
5.8.1.Market size and forecast
5.8.2.Market analysis, by country
CHAPTER 6:GLOBAL BIOINFORMATICS MARKET, BY SECTOR
6.1.Overview
6.1.1.Market size and forecast, by region
6.2.Medical bioinformatics
6.2.1.Market size and forecast, by region
6.2.2.Market analysis, by country
6.3.Animal bioinformatics
6.3.1.Market size and forecast, by region
6.3.2.Market analysis, by country
6.4.Agricultural bioinformatics
6.4.1.Market size and forecast by region
6.4.2.Market analysis, by country
6.5.Academics
6.5.1.Market size and forecast, by region
6.5.2.Market analysis, by country
6.6.Others
6.6.1.Market size and forecast, by region
6.6.2.Market analysis, by country
CHAPTER 7:BIOINFORMATICS MARKET, BY REGION
7.1.Overview
7.1.1.Market size and forecast
7.2.North America
7.2.1.Key market trends and opportunities
7.2.2.North America bioinformatics market, by country
7.2.2.1.U.S. bioinformatics market, by technology & services
7.2.2.2.U.S. bioinformatics market, by application
7.2.2.3.U.S. bioinformatics market, by sector
7.2.2.4.Canada bioinformatics market, by technology & services
7.2.2.5.Canada bioinformatics market, by application
7.2.2.6.Canada bioinformatics market, by sector
7.2.2.7.Mexico bioinformatics market, by technology & services
7.2.2.8.Mexico bioinformatics market, by application
7.2.2.9.Mexico bioinformatics market, by sector
7.2.3.North America bioinformatics market, by technology & services
7.2.4.North America bioinformatics market, by application
7.2.5.North America bioinformatics market, by sector
7.3.Europe
7.3.1.Key market trends and opportunities
7.3.2.Europe bioinformatics market, by country
7.3.2.1.Germany bioinformatics market, by technology & services
7.3.2.2.Germany bioinformatics market, by application
7.3.2.3.Germany bioinformatics market, by sector
7.3.2.4.France bioinformatics market, by technology & services
7.3.2.5.France bioinformatics market, by application
7.3.2.6.France bioinformatics market, by sector
7.3.2.7.UK bioinformatics market, by technology & services
7.3.2.8.UK bioinformatics market, by application
7.3.2.9.UK bioinformatics market, by sector
7.3.2.10.Italy bioinformatics market, by technology & services
7.3.2.11.Italy bioinformatics market, by application
7.3.2.12.Italy bioinformatics market, by sector
7.3.2.13.Spain bioinformatics market, by technology & services
7.3.2.14.Spain bioinformatics market, by application
7.3.2.15.Spain bioinformatics market, by sector
7.3.2.16.Rest of Europe bioinformatics market, by technology & services
7.3.2.17.Rest of Europe bioinformatics market, by application
7.3.2.18.Rest of Europe bioinformatics market, by sector
7.3.3.Europe bioinformatics market, by technology & services
7.3.4.Europe bioinformatics market, by application
7.3.5.Europe bioinformatics market, by sector
7.4.Asia-Pacific
7.4.1.Key market trends and opportunities
7.4.2.Asia-Pacific bioinformatics market, by country
7.4.2.1.Japan bioinformatics market, by technology & services
7.4.2.2.Japan bioinformatics market, by application
7.4.2.3.Japan bioinformatics market, by sector
7.4.2.4.China bioinformatics market, by technology & services
7.4.2.5.China bioinformatics market, by application
7.4.2.6.China bioinformatics market, by sector
7.4.2.7.India bioinformatics market, by technology & services
7.4.2.8.India bioinformatics market, by application
7.4.2.9.India bioinformatics market, by sector
7.4.2.10.Australia bioinformatics market, by technology & services
7.4.2.11.Australia bioinformatics market, by application
7.4.2.12.Australia bioinformatics market, by sector
7.4.2.13.South Korea bioinformatics market, by technology & services
7.4.2.14.South Korea bioinformatics market, by application
7.4.2.15.South Korea bioinformatics market, by sector
7.4.2.16.Taiwan bioinformatics market, by technology & services
7.4.2.17.Taiwan bioinformatics market, by application
7.4.2.18.Taiwan bioinformatics market, by sector
7.4.2.19.Rest of Asia-Pacific bioinformatics market, by technology & services
7.4.2.20.Rest of Asia-Pacific bioinformatics market, by application
7.4.2.21.Rest of Asia-Pacific bioinformatics market, by sector
7.4.3.Asia-Pacific bioinformatics market, by technology & services
7.4.4.Asia-Pacific bioinformatics market, by application
7.4.5.Asia-Pacific bioinformatics market, by sector
7.5.LAMEA
7.5.1.Key market trends and opportunities
7.5.2.LAMEA bioinformatics market, by country
7.5.2.1.Brazil bioinformatics market, by technology & services
7.5.2.2.Brazil bioinformatics market, by application
7.5.2.3.Brazil bioinformatics market, by sector
7.5.2.4.Saudi Arabia bioinformatics market, by technology & services
7.5.2.5.Saudi Arabia bioinformatics market, by application
7.5.2.6.Saudi Arabia bioinformatics market, by sector
7.5.2.7.South Africa bioinformatics market, by technology & services
7.5.2.8.South Africa bioinformatics market, by application
7.5.2.9.South Africa bioinformatics market, by sector
7.5.2.10.Rest of LAMEA bioinformatics market, by technology & services
7.5.2.11.Rest of LAMEA bioinformatics market, by application
7.5.2.12.Rest of LAMEA bioinformatics market, by sector
7.5.3.LAMEA bioinformatics market, by technology & services
7.5.4.LAMEA bioinformatics market, by application
7.5.5.LAMEA bioinformatics market, by sector
CHAPTER 8:COMPANY PROFILES
8.1.AGILENT TECHNOLOGIES, INC.
8.1.1.Company overview
8.1.2.Company snapshot
8.1.3.Operating business segments
8.1.4.Product portfolio
8.1.5.Business performance
8.2.BIOMAX INFORMATICS AG
8.2.1.Company overview
8.2.2.Company snapshot
8.2.3.Operating business segments
8.2.4.Product Portfolio
8.2.5.Key strategic moves and developments
8.3.DNANEXUS, INC.
8.3.1.Company overview
8.3.2.Company snapshot
8.3.3.Operating business segments
8.3.4.Product portfolio
8.3.5.Key strategic moves and developments
8.4.GENEDATA AG
8.4.1.Company overview
8.4.2.Company snapshot
8.4.3.Operating business segments
8.4.4.Product portfolio
8.5.INTREXON BIOINFORMATICS GERMANY GMBH
8.5.1.Company overview
8.5.2.Company snapshot
8.5.3.Operating business segments
8.5.4.Product portfolio
8.5.5.Key strategic moves and developments
8.6.ILLUMINA, INC.
8.6.1.Company overview
8.6.2.Company snapshot
8.6.3.Operating business segments
8.6.4.Product portfolio
8.6.5.Business performance
8.6.6.Key strategic moves and developments
8.7.PERKINELMER, INC.
8.7.1.Company overview
8.7.2.Company snapshot
8.7.3.Operating business segments
8.7.4.Product portfolio
8.7.5.Business performance
8.8.QIAGEN N.V.
8.8.1.Company overview
8.8.2.Company snapshot
8.8.3.Operating business segment
8.8.4.Product portfolio
8.8.5.Business performance
8.8.6.Key strategic moves and developments
8.9.SEVEN BRIDGES GENOMICS INC.
8.9.1.Company overview
8.9.2.Company snapshot
8.9.3.Operating business segments
8.9.4.Product Portfolio
8.9.5.Key strategic moves and developments
8.10.THERMO FISHER SCIENTIFIC, INC.
8.10.1.Company overview
8.10.2.Company snapshot
8.10.3.Operating business segment
8.10.4.Product portfolio
8.10.5.Business performance
LIST OF TABLES
TABLE 01.BIOINFORMATICS MARKET, BY TECHNOLOGY & SERVICES, 2019–2027 ($MILLION)
TABLE 02.BIOINFORMATICS MARKET FOR KNOWLEDGE MANAGEMENT TOOLS, BY TYPE, 2019–2027 ($MILLION)
TABLE 03.BIOINFORMATICS MARKET FOR KNOWLEDGE MANAGEMENT TOOLS, BY REGION, 2019–2027 ($MILLION)
TABLE 04.BIOINFORMATICS MARKET FOR BIOINFORMATICS PLATFORMS, BY TYPE, 2019–2027 ($MILLION)
TABLE 05.BIOINFORMATICS MARKET FOR BIOINFORMATICS PLATFORMS, BY REGION, 2019–2027 ($MILLION)
TABLE 06.BIOINFORMATICS MARKET FOR BIOINFORMATICS SERVICES, BY TYPE, 2019–2027 ($MILLION)
TABLE 07.BIOINFORMATICS MARKET FOR BIOINFORMATICS SERVICES, BY REGION, 2019–2027 ($MILLION)
TABLE 08.BIOINFORMATICS MARKET, BY APPLICATION 2019–2027 ($MILLION)
TABLE 09.BIOINFORMATICS MARKET FOR GENOMICS, BY REGION 2019–2027 ($MILLION)
TABLE 10.BIOINFORMATICS MARKET FOR CHEMOINFORMATICS & DRUG DESIGN, BY REGION 2019–2027 ($MILLION)
TABLE 11.BIOINFORMATICS MARKET FOR PROTEOMICS, BY REGION 2019–2027 ($MILLION)
TABLE 12.BIOINFORMATICS MARKET FOR TRANSCRIPTOMICS, BY REGION 2019–2027 ($MILLION)
TABLE 13.BIOINFORMATICS MARKET FOR METABOLOMICS, BY REGION 2019–2027 ($MILLION)
TABLE 14.BIOINFORMATICS MARKET FOR MOLECULAR PHYLOGENETICS, BY REGION, 2019–2027 ($MILLION)
TABLE 15.BIOINFORMATICS MARKET FOR OTHERS, BY REGION 2019–2027 ($MILLION)
TABLE 16.BIOINFORMATICS MARKET, BY SECTOR, 2019–2027 ($MILLION)
TABLE 17.BIOINFORMATICS MARKET FOR MEDICAL BIOINFORMATICS, BY REGION 2019–2027 ($MILLION)
TABLE 18.BIOINFORMATICS MARKET FOR ANIMAL BIOINFORMATICS, BY REGION 2019–2027 ($MILLION)
TABLE 19.BIOINFORMATICS MARKET FOR AGRICULTURE BIOINFORMATICS, BY REGION 2019–2027 ($MILLION)
TABLE 20.BIOINFORMATICS MARKET FOR ACADEMICS, BY REGION 2019–2027 ($MILLION)
TABLE 21.BIOINFORMATICS MARKET FOR OTHERS, BY REGION 2019–2027 ($MILLION)
TABLE 22.BIOINFORMATICS MARKET, BY REGION, 2019–2027 ($MILLION)
TABLE 23.NORTH AMERICA BIOINFORMATICS MARKET, BY COUNTRY, 2019–2027 ($MILLION)
TABLE 24.U.S. BIOINFORMATICS MARKET, BY TECHNOLOGY & SERVICES, 2019–2027 ($MILLION)
TABLE 25.U.S. BIOINFORMATICS MARKET, BY APPLICATION, 2019–2027 ($MILLION)
TABLE 26.U.S. BIOINFORMATICS MARKET, BY SECTOR, 2019–2027 ($MILLION)
TABLE 27.CANADA BIOINFORMATICS MARKET, BY TECHNOLOGY & SERVICES, 2019–2027 ($MILLION)
TABLE 28.CANADA BIOINFORMATICS MARKET, BY APPLICATION, 2019–2027 ($MILLION)
TABLE 29.CANADA BIOINFORMATICS MARKET, BY SECTOR, 2019–2027 ($MILLION)
TABLE 30.MEXICO BIOINFORMATICS MARKET, BY TECHNOLOGY & SERVICES, 2019–2027 ($MILLION)
TABLE 31.MEXICO BIOINFORMATICS MARKET, BY APPLICATION, 2019–2027 ($MILLION)
TABLE 32.MEXICO BIOINFORMATICS MARKET, BY SECTOR, 2019–2027 ($MILLION)
TABLE 33.NORTH AMERICA BIOINFORMATICS MARKET, BY TECHNOLOGY & SERVICES, 2019–2027 ($MILLION)
TABLE 34.NORTH AMERICA BIOINFORMATICS MARKET, BY APPLICATION, 2019–2027 ($MILLION)
TABLE 35.NORTH AMERICA BIOINFORMATICS MARKET, BY SECTOR, 2019–2027 ($MILLION)
TABLE 36.EUROPE BIOINFORMATICS MARKET, BY COUNTRY, 2019–2027 ($MILLION)
TABLE 37.GERMANY BIOINFORMATICS MARKET, BY TECHNOLOGY & SERVICES, 2019–2027 ($MILLION)
TABLE 38.GERMANY BIOINFORMATICS MARKET, BY APPLICATION, 2019–2027 ($MILLION)
TABLE 39.GERMANY BIOINFORMATICS MARKET, BY SECTOR, 2019–2027 ($MILLION)
TABLE 40.FRANCE BIOINFORMATICS MARKET, BY TECHNOLOGY & SERVICES, 2019–2027 ($MILLION)
TABLE 41.FRANCE BIOINFORMATICS MARKET, BY APPLICATION, 2019–2027 ($MILLION)
TABLE 42.FRANCE BIOINFORMATICS MARKET, BY SECTOR, 2019–2027 ($MILLION)
TABLE 43.UK BIOINFORMATICS MARKET, BY TECHNOLOGY & SERVICES, 2019–2027 ($MILLION)
TABLE 44.UK BIOINFORMATICS MARKET, BY APPLICATION, 2019–2027 ($MILLION)
TABLE 45.UK BIOINFORMATICS MARKET, BY SECTOR, 2019–2027 ($MILLION)
TABLE 46.ITALY BIOINFORMATICS MARKET, BY TECHNOLOGY & SERVICES, 2019–2027 ($MILLION)
TABLE 47.ITALY BIOINFORMATICS MARKET, BY APPLICATION, 2019–2027 ($MILLION)
TABLE 48.ITALY BIOINFORMATICS MARKET, BY SECTOR, 2019–2027 ($MILLION)
TABLE 49.SPAIN BIOINFORMATICS MARKET, BY TECHNOLOGY & SERVICES, 2019–2027 ($MILLION)
TABLE 50.SPAIN BIOINFORMATICS MARKET, BY APPLICATION, 2019–2027 ($MILLION)
TABLE 51.SPAIN BIOINFORMATICS MARKET, BY SECTOR, 2019–2027 ($MILLION)
TABLE 52.REST OF EUROPE BIOINFORMATICS MARKET, BY TECHNOLOGY & SERVICES, 2019–2027 ($MILLION)
TABLE 53.REST OF EUROPE BIOINFORMATICS MARKET, BY APPLICATION, 2019–2027 ($MILLION)
TABLE 54.REST OF EUROPE BIOINFORMATICS MARKET, BY SECTOR, 2019–2027 ($MILLION)
TABLE 55.EUROPE BIOINFORMATICS MARKET, BY TECHNOLOGY & SERVICES, 2019–2027 ($MILLION)
TABLE 56.EUROPE BIOINFORMATICS MARKET, BY APPLICATION, 2019–2027 ($MILLION)
TABLE 57.EUROPE BIOINFORMATICS MARKET, BY SECTOR, 2019–2027 ($MILLION)
TABLE 58.ASIA-PACIFIC BIOINFORMATICS MARKET, BY COUNTRY, 2019–2027 ($MILLION)
TABLE 59.JAPAN BIOINFORMATICS MARKET, BY TECHNOLOGY & SERVICES, 2019–2027 ($MILLION)
TABLE 60.JAPAN BIOINFORMATICS MARKET, BY APPLICATION, 2019–2027 ($MILLION)
TABLE 61.JAPAN BIOINFORMATICS MARKET, BY SECTOR, 2019–2027 ($MILLION)
TABLE 62.CHINA BIOINFORMATICS MARKET, BY TECHNOLOGY & SERVICES, 2019–2027 ($MILLION)
TABLE 63.CHINA BIOINFORMATICS MARKET, BY APPLICATION, 2019–2027 ($MILLION)
TABLE 64.CHINA BIOINFORMATICS MARKET, BY SECTOR, 2019–2027 ($MILLION)
TABLE 65.INDIA BIOINFORMATICS MARKET, BY TECHNOLOGY & SERVICES, 2019–2027 ($MILLION)
TABLE 66.INDIA BIOINFORMATICS MARKET, BY APPLICATION, 2019–2027 ($MILLION)
TABLE 67.INDIA BIOINFORMATICS MARKET, BY SECTOR, 2019–2027 ($MILLION)
TABLE 68.AUSTRALIA BIOINFORMATICS MARKET, BY TECHNOLOGY & SERVICES, 2019–2027 ($MILLION)
TABLE 69.AUSTRALIA BIOINFORMATICS MARKET, BY APPLICATION, 2019–2027 ($MILLION)
TABLE 70.AUSTRALIA BIOINFORMATICS MARKET, BY SECTOR, 2019–2027 ($MILLION)
TABLE 71.SOUTH KOREA BIOINFORMATICS MARKET, BY TECHNOLOGY & SERVICES, 2019–2027 ($MILLION)
TABLE 72.SOUTH KOREA BIOINFORMATICS MARKET, BY APPLICATION, 2019–2027 ($MILLION)
TABLE 73.SOUTH KOREA BIOINFORMATICS MARKET, BY SECTOR, 2019–2027 ($MILLION)
TABLE 74.TAIWAN BIOINFORMATICS MARKET, BY TECHNOLOGY & SERVICES, 2019–2027 ($MILLION)
TABLE 75.TAIWAN BIOINFORMATICS MARKET, BY APPLICATION, 2019–2027 ($MILLION)
TABLE 76.TAIWAN BIOINFORMATICS MARKET, BY SECTOR, 2019–2027 ($MILLION)
TABLE 77.REST OF ASIA-PACIFIC BIOINFORMATICS MARKET, BY TECHNOLOGY & SERVICES, 2019–2027 ($MILLION)
TABLE 78.REST OF ASIA-PACIFIC BIOINFORMATICS MARKET, BY APPLICATION, 2019–2027 ($MILLION)
TABLE 79.REST OF ASIA-PACIFIC BIOINFORMATICS MARKET, BY SECTOR, 2019–2027 ($MILLION)
TABLE 80.ASIA-PACIFIC BIOINFORMATICS MARKET, BY TECHNOLOGY & SERVICES, 2019–2027 ($MILLION)
TABLE 81.ASIA-PACIFIC BIOINFORMATICS MARKET, BY APPLICATION, 2019–2027 ($MILLION)
TABLE 82.ASIA-PACIFIC BIOINFORMATICS MARKET, BY SECTOR, 2019–2027 ($MILLION)
TABLE 83.LAMEA BIOINFORMATICS MARKET, BY COUNTRY, 2019–2027 ($MILLION)
TABLE 84.BRAZIL BIOINFORMATICS MARKET, BY TECHNOLOGY & SERVICES, 2019–2027 ($MILLION)
TABLE 85.BRAZIL BIOINFORMATICS MARKET, BY APPLICATION, 2019–2027 ($MILLION)
TABLE 86.BRAZIL BIOINFORMATICS MARKET, BY SECTOR, 2019–2027 ($MILLION)
TABLE 87.SAUDI ARABIA BIOINFORMATICS MARKET, BY TECHNOLOGY & SERVICES, 2019–2027 ($MILLION)
TABLE 88.SAUDI ARABIA BIOINFORMATICS MARKET, BY APPLICATION, 2019–2027 ($MILLION)
TABLE 89.SAUDI ARABIA BIOINFORMATICS MARKET, BY SECTOR, 2019–2027 ($MILLION)
TABLE 90.SOUTH AFRICA BIOINFORMATICS MARKET, BY TECHNOLOGY & SERVICES, 2019–2027 ($MILLION)
TABLE 91.SOUTH AFRICA BIOINFORMATICS MARKET, BY APPLICATION, 2019–2027 ($MILLION)
TABLE 92.SOUTH AFRICA BIOINFORMATICS MARKET, BY SECTOR, 2019–2027 ($MILLION)
TABLE 93.REST OF LAMEA BIOINFORMATICS MARKET, BY TECHNOLOGY & SERVICES, 2019–2027 ($MILLION)
TABLE 94.REST OF LAMEA BIOINFORMATICS MARKET, BY APPLICATION, 2019–2027 ($MILLION)
TABLE 95.REST OF LAMEA BIOINFORMATICS MARKET, BY SECTOR, 2019–2027 ($MILLION)
TABLE 96.LAMEA BIOINFORMATICS MARKET, BY TECHNOLOGY & SERVICES, 2019–2027 ($MILLION)
TABLE 97.LAMEA BIOINFORMATICS MARKET, BY APPLICATION, 2019–2027 ($MILLION)
TABLE 98.LAMEA BIOINFORMATICS MARKET, BY SECTOR, 2019–2027 ($MILLION)
TABLE 99.AGILENT: COMPANY SNAPSHOT
TABLE 100.AGILENT: OERATING SEGMENT
TABLE 101.AGILENT: PRODUCT PORTFOLIO
TABLE 102.BIOMAX INFORMATICS : COMPANY SNAPSHOT
TABLE 103.BIOMAX INFORMATICS : OPERATING SEGMENTS
TABLE 104.BIOMAX INFORMATICS: PRODUCT PORTFOLIO
TABLE 105.DNANEXUS: COMPANY SNAPSHOT
TABLE 106.DNANEXUS: OPERATING SEGMENTS
TABLE 107.DNANEXUS: PRODUCT PORTFOLIO
TABLE 108.GENEDATA: COMPANY SNAPSHOT
TABLE 109.GENEDATA: OPERATING SEGMENTS
TABLE 110.GENEDATA: PRODUCT PORTFOLIO
TABLE 111.INTREXON: COMPANY SNAPSHOT
TABLE 112.INTREXON: OPERATING SEGMENTS
TABLE 113.INTREXON: PRODUCT PORTFOLIO
TABLE 114.ILLUMINA: COMPANY SNAPSHOT
TABLE 115.ILLUMINA: OPERATING SEGMENTS
TABLE 116.ILLUMINA: PRODUCT PORTFOLIO
TABLE 117.PERKINELMER: COMPANY SNAPSHOT
TABLE 118.PERKINELMER: OPERATING SEGMENT
TABLE 119.PERKINELMER: PRODUCT PORTFOLIO
TABLE 120.QIAGEN: COMPANY SNAPSHOT
TABLE 121.QIAGEN: PRODUCT SEGMENT
TABLE 122.QIAGEN: PRODUCT PORTFOLIO
TABLE 123.SEVEN BRIDGES: COMPANY SNAPSHOT
TABLE 124.SEVEN BRIDGES: OPERATING SEGMENTS
TABLE 125.SEVEN BRIDGES: PRODUCT PORTFOLIO
TABLE 126.THERMO FISHER SCIENTIFIC.: COMPANY SNAPSHOT
TABLE 127.THERMO FISHER SCIENTIFIC: PRODUCT SEGMENT
TABLE 128.THERMO FISHER SCIENTIFIC: PRODUCT PORTFOLIO
LIST OF FIGURES
FIGURE 01.TOP INVESTMENT POCKETS, 2019
FIGURE 02.TOP WINNING STRATEGIES, BY YEAR, 2018–2020*
FIGURE 03.TOP WINNING STRATEGIES, BY DEVELOPMENT, 2018–2020* (%)
FIGURE 04.TOP WINNING STRATEGIES, BY COMPANY, 2018–2020*
FIGURE 05.TOP PLAYER POSITIONING, 2019
FIGURE 06.LOW BARGAINING POWER OF SUPPLIERS
FIGURE 07.HIGH BARGAINING POWER OF BUYERS
FIGURE 08.MODERATE THREAT OF SUBSTITUTION
FIGURE 09.MODERATE THREAT OF NEW ENTRANT
FIGURE 10.HIIGH COMPETITIVE RIVALRY
FIGURE 11.VALUE CHAIN ANALYSIS
FIGURE 12.PATENTS ANALYSIS BY YEAR, 2017 TO 2019
FIGURE 13.PATENT ANALYSIS, BY COUNTRY (2017–2019)
FIGURE 14.PATENT ANALYSIS, BY APPLICANT (2017–2019)
FIGURE 15.GENERALIZED KNOWLEDGE MANAGEMENT TOOLS MARKET, 2019–2027 ($MILLION)
FIGURE 16.SPECIALIZED KNOWLEDGE MANAGEMENT TOOLS MARKET, 2019–2027 ($MILLION)
FIGURE 17.COMPARATIVE ANALYSIS OF BIOINFORMATICS MARKET FOR KNOWLEDGE MANAGEMENT TOOLS, BY COUNTRY, 2019 & 2027 ($MILLION)
FIGURE 18.SEQUENCE ANALYSIS PLATFORM MARKET, 2019–2027 ($MILLION)
FIGURE 19.SEQUENCE ALIGNMENT PLATFORM MARKET, 2019–2027 ($MILLION)
FIGURE 20.SEQUENCE MANIPULATION PLATFORMS MARKET, 2019–2027 ($MILLION)
FIGURE 21.STRUCTURAL ANALYSIS PLATFORMS MARKET, 2019–2027 ($MILLION)
FIGURE 22.OTHER BIOINFORMATICS PLATFORM MARKET, 2019–2027 ($MILLION)
FIGURE 23.COMPARATIVE ANALYSIS OF BIOINFORMATICS MARKET FOR BIOINFORMATICS PLATFORMS, BY COUNTRY, 2019 & 2027 ($MILLION)
FIGURE 24.SEQUENCE SERVICES MARKET, 2019–2027 ($MILLION)
FIGURE 25.DATABASE MANAGEMENT BIOINFORMATICS MARKET, 2019–2027 ($MILLION)
FIGURE 26.DATA ANALYSIS BIOINFORMATICS MARKET, 2019–2027 ($MILLION)
FIGURE 27.OTHERS MARKET, 2019–2027 ($MILLION)
FIGURE 28.COMPARATIVE ANALYSIS OF BIOINFORMATICS MARKET FOR BIOINFORMATICS SERVICES, BY COUNTRY, 2019 & 2027 ($MILLION)
FIGURE 29.COMPARATIVE SHARE ANALYSIS OF BIOINFORMATICS MARKET FOR GENOMICS, BY COUNTRY, 2019 & 2027 (%)
FIGURE 30.COMPARATIVE SHARE ANALYSIS OF BIOINFORMATICS MARKET FOR CHEMOINFORMATICS AND DRUG DESIGN, BY COUNTRY, 2017 & 2025 (%)
FIGURE 31.COMPARATIVE SHARE ANALYSIS OF BIOINFORMATICS MARKET FOR PROTEOMICS, BY COUNTRY, 2019 & 2027 (%)
FIGURE 32.COMPARATIVE SHARE ANALYSIS OF BIOINFORMATICS MARKET FOR TRANSCRIPTOMICS, BY COUNTRY, 2019 & 2027 (%)
FIGURE 33.COMPARATIVE SHARE ANALYSIS OF BIOINFORMATICS MARKET FOR METABOLOMICS, BY COUNTRY, 2019 & 2027 (%)
FIGURE 34.COMPARATIVE SHARE ANALYSIS OF BIOINFORMATICS MARKET FOR MOLECULAR PHYLOGENETICS, BY COUNTRY, 2019 & 2027 (%)
FIGURE 35.COMPARATIVE SHARE ANALYSIS OF BIOINFORMATICS MARKET OTHERS, BY COUNTRY, 2019 & 2027 (%)
FIGURE 36.COMPARATIVE SHARE ANALYSIS OF BIOINFORMATICS MARKET FOR MEDICAL BIOINFORMATICS, BY COUNTRY, 2019 & 2027 (%)
FIGURE 37.COMPARATIVE SHARE ANALYSIS OF BIOINFORMATICS MARKET FOR ANIMAL BIOINFORMATICS, BY COUNTRY, 2019 & 2027 (%)
FIGURE 38.COMPARATIVE SHARE ANALYSIS OF BIOINFORMATICS MARKET FOR AGRICULTURE BIOINFORMATICS, BY COUNTRY, 2019 & 2027 (%)
FIGURE 39.COMPARATIVE SHARE ANALYSIS OF BIOINFORMATICS MARKET FOR ACADEMICS, BY COUNTRY, 2019 & 2027 (%)
FIGURE 40.COMPARATIVE SHARE ANALYSIS OF BIOINFORMATICS MARKET FOR OTHERS, BY COUNTRY, 2019 & 2027 (%)
FIGURE 41.AGILENT: NET SALES, 2017–2019 ($MILLION)
FIGURE 42.AGILENT: REVENUE SHARE, BY SEGMENT, 2019 (%)
FIGURE 43.AGILENT: REVENUE SHARE, BY REGION, 2019 (%)
FIGURE 44.ILLUMINA: NET SALES, 2017–2019 ($MILLION)
FIGURE 45.ILLUMINA: REVENUE SHARE, BY SEGMENT, 2019 (%)
FIGURE 46.ILLUMINA: REVENUE SHARE, BY REGION, 2019 (%)
FIGURE 47.PERKINELMER: NET SALES, 2017–2019 ($MILLION)
FIGURE 48.PERKINELMER: REVENUE SHARE, BY SEGMENT, 2019 (%)
FIGURE 49.PERKINELMER: REVENUE SHARE, BY REGION, 2019 (%)
FIGURE 50.QIAGEN: NET SALES, 2017–2019 ($MILLION)
FIGURE 51.QIAGEN: REVENUE SHARE, BY PRODUCT, 2019 (%)
FIGURE 52.QIAGEN: REVENUE SHARE, BY REGION, 2019 (%)
FIGURE 53.THERMO FISHER SCIENTIFIC: NET SALES, 2017–2019 ($MILLION)
FIGURE 54.THERMO FISHER SCIENTIFIC: REVENUE SHARE, BY SEGMENT, 2019 (%)
FIGURE 55.THERMO FISHER SCIENTIFIC. REVENUE SHARE, BY REGION, 2019 (%)
